“Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes” (2016) International Journal of Biomedical Research, 7(5), pp. 276–282. doi:10.7439/ijbr.v7i5.3273.